Nuveen LLC Purchases New Holdings in Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• Nuveen LLC invested approximately $58.87 million in Haleon PLC by acquiring 5,721,131 shares as reported in their recent SEC filing.
• Several large investors have increased their holdings in Haleon, with some firms like Deutsche Bank AG growing their stake by over 267% during the first quarter.
• Haleon announced an increase in its semi-annual dividend to $0.0555, reflecting a dividend yield of 190.0%, up from the previous $0.05.

Nuveen LLC purchased a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 5,721,131 shares of the company's stock, valued at approximately $58,870,000. Nuveen LLC owned approximately 0.13% of Haleon at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Bartlett & CO. Wealth Management LLC increased its position in shares of Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after acquiring an additional 1,491 shares during the period. Opal Wealth Advisors LLC purchased a new stake in Haleon in the first quarter valued at $29,000. Deutsche Bank AG boosted its holdings in Haleon by 267.8% in the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock valued at $32,000 after purchasing an additional 2,276 shares during the last quarter. Continuum Advisory LLC boosted its holdings in Haleon by 152.4% in the first quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock valued at $49,000 after purchasing an additional 2,870 shares during the last quarter. Finally, Alpine Bank Wealth Management purchased a new stake in Haleon in the first quarter valued at $56,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a report on Friday, May 9th. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. Barclays reissued an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Finally, BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a research note on Tuesday, May 27th. Five investment analysts have rated the stock with a hold rating, three have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Price Performance

Shares of HLN stock traded down $0.06 during mid-day trading on Friday, hitting $9.64. 7,875,929 shares of the stock were exchanged, compared to its average volume of 11,052,347. The firm has a fifty day moving average of $10.04 and a 200 day moving average of $10.20. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 52-week low of $8.86 and a 52-week high of $11.42. The company has a market cap of $43.30 billion, a PE ratio of 24.72, a price-to-earnings-growth ratio of 2.85 and a beta of 0.23.

Haleon Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be paid a $0.0555 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a yield of 190.0%. This is a boost from Haleon's previous semi-annual dividend of $0.05. Haleon's dividend payout ratio is 28.21%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.